Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Synergies to Provide a Catalyst for Riverbed Technology, Inc. (RVBD)

The market for network performance appliances has become so competitive that Riverbed Technology, Inc. (NASDAQ:RVBD) now trades at a below-market earnings multiple of 12. With the purchase of OPNET last year, the network performance company for globally connected enterprises is facing a weak market for network equipment while it still works to achieve the synergies promised as part of the merger

The network equipment sector is facing a couple of trends that impact revenue, including weak government spending and a transition to software or virtual based solutions. Not to mention that both Cisco Systems, Inc. (NASDAQ:CSCO) and F5 Networks, Inc. (NASDAQ:FFIV) have become more formidable competitors recently. These combined issues have caused investors to sell Riverbed down to an attractive valuation.

OPNET synergies

Riverbed Technology, Inc. (NASDAQ:RVBD)With the maturing of the core WAN optimization market, Riverbed Technology, Inc. (NASDAQ:RVBD) seized the opportunity to purchase a strong application performance management product company and expand it with the Riverbed distribution network. OPNET had limited international distribution and a weak enterprise sales profile. With the integration of the sales force during Q2, the combined company expects to achieve considerable synergies going forward.

The company wins with the only combined end-to-end solution in the network performance management and application performance management products. The increased distribution should help sell more OPNET products even without the synergy and combined solution benefits.

Also, importantly Riverbed Technology, Inc. (NASDAQ:RVBD) saw a strong 19% year-over-year increase in the US enterprise market, suggesting that the weakness in Europe and Asia could lead to strength in the second half of the year. The fears of a maturing WAN optimization market might be overdone with the real damage done by lower government spending and weak international economies that impacted all technology sectors.

Increasing competition

If the market wasn’t tough enough with the sequester in the US and austerity cuts in Europe, Riverbed Technology, Inc. (NASDAQ:RVBD) appears to be facing tougher competition in the core WAN optimization market. According to UBS, Riverbed’s market share fell from approximately 43% in the prior year to only 40% in Q1. Cisco Systems, Inc. (NASDAQ:CSCO) was able to maintain share at around 20% while F5 Networks, Inc. (NASDAQ:FFIV) grew to 7% of the market. Combined, the three firms control only 70% of the market, providing the ability to gain share in a market that still remains rather fragmented for a mature area.

While this data doesn’t back up the claims of Riverbed Technology, Inc. (NASDAQ:RVBD) management that it controls 50% of the market and wins 90% of the deals where it competes against Cisco, it does highlight a major concern for investors. Both Cisco and F5 are considerably larger firms with strong balance sheets, but companies that focus primarily on other markets.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.